Validating vision tests for concussion-related eye movement problems
Official title: Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
Run by Salus University · NCT07282691 · Data updated 2026-11-12
This project will test whether a set of visual endurance exams can reliably measure eye-movement problems in people 1–6 months after a mild concussion.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Salus University Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | September 29, 2028 |
| Study ends | September 29, 2028 |
| Registry record updated | December 15, 2025 |
| Trial ID | NCT07282691 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people 1 to 6 months after a mild traumatic brain injury who have near-normal distance acuity (≥20/25 in each eye) and symptomatic convergence insufficiency (CISS score >21).
✕Probably not a fit
Patients with moderate or severe TBI, significant ocular disease or manifest strabismus, recent intraocular injury, uncontrolled systemic diseases affecting eye movements, or cognitive impairments that prevent testing are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Investigators will recruit 50 people with a recent mTBI and 100 people without mTBI to compare performance on a series of visual endurance tests that require sustained visual responses. Participants will undergo standardized vision examinations to confirm acuity and screen for other eye diseases, then complete the endurance protocols while researchers record objective performance and symptom reports. The team will calculate expected values for each test, look at variability between individuals, and collect qualitative data about discomfort or symptom provocation during testing. Results will be used to determine which measures are reliable and feasible as outcome measures in future rehabilitation studies.
Why it matters
Potential benefit: If successful, these validated tests could give clinicians and researchers reliable tools to measure concussion-related oculomotor dysfunction and track recovery or response to treatments.
How similar studies have gone: Prior smaller studies of oculomotor and convergence testing have shown promising signals, but formal validation of sustained visual endurance measures specifically in mTBI is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of mTBI within previous 1 to 6 months * Distance visual acuity better than or equal to 20/25 in each eye * Score \>21 on Convergence Insufficiency Symptom Survey Exclusion Criteria: * Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness * Not wearing required refractive error) * Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination) * Cognitive delays that may impact testing
Where it's running
-
The Eye Institute
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Katie Holmbeck, BS
- Email: kh3482@drexel.edu
- Phone: 2157801429
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury
A group therapy program based on EAET is tested to see if it helps adults 18-65 with acquired brain injury improve emotional well-being and daily functioning.
-
BCAAs in Concussion: a higher-dose test in teens and young adults
This trial will test whether high-dose branched-chain amino acids help teens and young adults recover from concussion compared with a placebo.
-
HeadPulse for detecting concussion and tracking recovery
This project will test whether the HeadPulse device can detect concussion and track recovery in people age 4 and up who have had a mild traumatic brain injury, with a focus on athletes.
-
Retraining Neural Pathways to Improve Working Memory After Mild TBI
This study tests PATH+DigitMemory neurotraining to see if it can improve working memory after a mild traumatic brain injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.